Re-analysis of survival data of cancer patients utilizing additive homeopathy

Gleiss, Andreas; Frass, Michael; Gaertner, Katharina (2016). Re-analysis of survival data of cancer patients utilizing additive homeopathy. Complementary therapies in medicine, 27, pp. 65-67. Elsevier 10.1016/j.ctim.2016.06.001

[img] Text
2016_Gleiss, Frass, Gaertner_Re-analysis of survival data of cancer patients utilizing additive homeopathy.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (344kB) | Request a copy

In this short communication we present a re-analysis of homeopathic patient data in comparison to control patient data from the same Outpatient's Unit "Homeopathy in malignant diseases" of the Medical University of Vienna. In this analysis we took account of a probable immortal time bias. For patients suffering from advanced stages of cancer and surviving the first 6 or 12 months after diagnosis, respectively, the results show that utilizing homeopathy gives a statistically significant (p<0.001) advantage over control patients regarding survival time. In conclusion, bearing in mind all limitations, the results of this retrospective study suggest that patients with advanced stages of cancer might benefit from additional homeopathic treatment until a survival time of up to 12 months after diagnosis.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Medical Education > Institute of Complementary Medicine (ICOM)

UniBE Contributor:

Gaertner, Katharina

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0965-2299

Publisher:

Elsevier

Language:

English

Submitter:

Martin Frei-Erb

Date Deposited:

29 Dec 2016 16:33

Last Modified:

29 Dec 2016 16:33

Publisher DOI:

10.1016/j.ctim.2016.06.001

PubMed ID:

27515878

BORIS DOI:

10.7892/boris.91080

URI:

https://boris.unibe.ch/id/eprint/91080

Actions (login required)

Edit item Edit item
Provide Feedback